NIG
GMAB icon

NFJ Investment Group’s Genmab GMAB Stock Holding History

NFJ Investment Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-48
Closed -$1.47K – 258
2025
Q3 		$1.47K Hold
48
– – ﹤0.01% 260
2025
Q2 		$992 Sell
48
-8,470
-99% -$174K ﹤0.01% 271
2025
Q1 		$167K Sell
8,518
-1,667
-16% -$35K 0.01% 268
2024
Q4 		$213K Sell
10,185
-2,059
-17% -$45.2K 0.01% 261
2024
Q3 		$299K Buy
12,244
+4
+0% +$107 0.01% 261
2024
Q2 		$308K Sell
12,240
-12,522
-51% -$355K 0.01% 234
2024
Q1 		$741K Sell
24,762
-3,645
-13% -$107K 0.02% 218
2023
Q4 		$904K Buy
+28,407
New +$892K 0.03% 205

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NFJ Investment Group's GMAB Position: Q4 2025 in Review

NFJ Investment Group sold out of Genmab (GMAB) in Q4 2025, closing a stake of 48 shares — an estimated $1.47K sold.

NFJ Investment Group first reported a position in GMAB in Q4 2023 and held it in 8 quarters. The position peaked at $904K in Q4 2023. 293 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

  • NFJ Investment Group reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
  • NFJ Investment Group sold 48 Genmab shares in Q4 2025, an estimated $1.47K.
  • NFJ Investment Group first reported a position in Genmab in Q4 2023 and held it in 8 quarters.
  • NFJ Investment Group's Genmab position peaked at $904K in Q4 2023.
  • 293 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on NFJ Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.